|
2 Companies |
|
2 Products |
|
2 Products |
|
6 Mechanisms of Action |
|
0 Trials |
|
7 News |
|
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: DYNAMAT: Brain Maturation in Children With Localization Related Epilepsy (clinicaltrials.gov) - Dec 21, 2018
P=N/A, N=101, Completed, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed | Trial completion date: Jul 2020 --> Dec 2018 | Trial primary completion date: Jul 2020 --> Dec 2018
- | levetiracetam / Generic mfg.
Trial completion, Enrollment change: Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children (clinicaltrials.gov) - Nov 14, 2017
P1, N=108, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Active, not recruiting --> Completed | Trial completion date: Jul 2020 --> Dec 2018 | Trial primary completion date: Jul 2020 --> Dec 2018 Active, not recruiting --> Completed | N=144 --> 108
- | levetiracetam / Generic mfg.
Enrollment closed, Trial primary completion date: Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children (clinicaltrials.gov) - Feb 23, 2017
P1, N=144, Active, not recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
Active, not recruiting --> Completed | N=144 --> 108 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Jun 2017
- New trial: DYNAMAT: Brain Maturation in Children With Localization Related Epilepsy (clinicaltrials.gov) - Jan 7, 2016
P=N/A, N=101, Active, not recruiting, Sponsor: Hospices Civils de Lyon
- | Trial completion: The Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment Study (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=47, Completed, Sponsor: Maastricht University Medical Center
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Jun 2017 Active, not recruiting --> Completed
- Enrollment closed: The Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment Study (clinicaltrials.gov) - Jun 23, 2013
P=N/A, N=40, Active, not recruiting, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- levetiracetam / Generic mfg.
New P1 trial: Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children (clinicaltrials.gov) - Jan 26, 2012
P1, N=144, Recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati